Lexeo Therapeutics Average Rating is 'Buy' with a Price Target of $22.40

Summary

According to a survey by FactSet, the average rating for Lexeo Therapeutics is ‘Buy’, with an average price target of $22.40.Trading View

Impact Analysis

This event is at the company level, focusing on Lexeo Therapeutics. The consensus among analysts is positive, reflected by a ‘Buy’ rating and price targets ranging between $22.40 and $24.00, indicating investor confidence in the company’s potential for stock appreciation.Market Beat+ 2 The inference graph shows that the direct impact is increased market interest in Lexeo Therapeutics, which could lead to a rise in stock prices. The first-order effect includes potential investor buying, driving up demand and possibly the stock price. The second-order effects could involve increased attention from other investors and analysts, reinforcing positive sentiment. Investment opportunities lie in buying Lexeo Therapeutics stock, potentially benefiting from the anticipated stock price increase as per the analysts’ targets.